In this podcast, Contributing Editor Professor Paul Moss has a conversation with Professor Johnny Mahlangu. They discuss Dr. Moss's Diffusion article from the November/December 2018 issue of The Hematologist. The article titled, "Mimicry Not Replacement: Molecular Engineering Transforms the Outlook in Hemophilia A," covers the HAVEN3 study, which focuses on the activity of prophylactic emicizumab in patients with hemophilia who do not have inhibitors. You can find his Diffusion article online at www.hematology.org/Thehematologist/Diffusion/9049.aspx.

Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

In this podcast, Dr. Robert Liem, Dr. Sophie Lanzkron, and Dr. Reem Mustafa discuss the clinical importance of ASH Guidelines on SCD, specifically the guideline opening September 24, 2018, for public comment, SCD-Related Cardiopulmonary and Kidney Disease. To access and comment on these guidelines, visit www.hematology.org/guidelines-public-comment. The comment period will open September 24 and close November 5, 2018. Additional ASH Guidelines on SCD will become available in 2019.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

In this podcast, Dr. Michael DeBaun and Dr. Hassan Murad discuss the clinical importance of ASH Guidelines on SCD, specifically the guideline opening September 24, 2018, for public comment, SCD-Related Cerebrovascular Disease. To access and comment on these guidelines, visit www.hematology.org/guidelines-public-comment. The comment period will open September 24 and close November 5, 2018. Additional ASH Guidelines on SCD will become available in 2019.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

In this podcast, Contributing Editor Dr. Annette Kim has a conversation with Dr. Davide Rossi. They discuss Dr. Kim's Diffusion article from the September/October 2018 issue of The Hematologist. The article titled, "Circulating Tumor DNA in Lymphoma Monitoring: Fantasy, Fad, or Fact?," covers a study that showcases the utility of circulating tumor DNA monitoring in classic Hodgkin lymphoma. You can find her Diffusion article online at www.hematology.org/Thehematologist/Diffusion/8943.aspx.

Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

In this podcast, Dr. Stella Chou and Dr. Jo Howard discuss the clinical importance of ASH Guidelines on SCD, specifically the guideline opening August 20, 2018, for public comment, SCD-Related Transfusion Support. To access and comment on these guidelines, visit www.hematology.org/guidelines-public-comment. The comment period will open August 20 and close October 1, 2018. Additional ASH Guidelines on SCD will become available in the next two months.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

In this podcast, former Chair of the ASH Trainee Council Dr. Leidy Isenalumhe and current Chair of the ASH Trainee Council Dr. Alex Boucher have a conversation about the re-imagined Trainee Day, now known as ASH-a-Palooza, taking place at the 2018 ASH Annual Meeting. ASH-a-Palooza will offer a relaxed, open learning environment for trainees in a festival-like setting with multiple opportunities for micro learning. The event will take place Friday, November 30, 2018, right before the annual meeting starts on Saturday, December 1. For additional details including a preliminary schedule and location information, visit www.hematology.org/ashapalooza.

Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

In this podcast, Dr. David Anderson and Dr. Philipp Dahm discuss the clinical importance of new ASH Guidelines on VTE, specifically the guideline currently open for public comment, Prevention of VTE in Surgical Patients. To access and comment on these guidelines, visit www.hematology.org/guidelines-public-comment. The comment period closes July 25, 2018. Additional ASH Guidelines on VTE will become available for comment online throughout the next four to six months.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

In this podcast, Contributing Editor Dr. Omar Abdel-Wahab has a conversation with Drs. Ulrich Steidl and Amit Verma. They discuss Dr. Abdel-Wahab's Diffusion article from the July/August 2018 issue of The Hematologist. The article titled, "New Means to Reactivate p53 in Leukemia: A Staple Peptide Inhibitor of MDMX and MDM2," discusses therapeutic activation of wild-type TP53 in leukemia and other forms of cancer. You can find the Diffusion article online at www.hematology.org/Thehematologist/Diffusion/8673.aspx.

Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

In this podcast, Chair of the ASH Committee on Practice Dr. Joseph Alvarnas and Chair of the ASH Committee on Government Affairs Dr. Alan Rosmarin talk about the ASH Congressional Fellowship, a unique opportunity for a hematologist to work in a congressional office on Capitol Hill for an academic year, to help shape health care and hematology policy. We also hear from Dr. Catherine Zander, the first ever ASH Congressional Fellow, as she shares her personal experience with the fellowship. For more information, visit www.hematology.org/congressionalfellowship.

Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

In this podcast, Contributing Editor Dr. Caron Jacobson and Dr. Marcela Maus both of Dana Farber Cancer Institute have a thought provoking conversation. They discuss Dr. Jacobson's Diffusion article from the May/June 2018 issue of The Hematologist. The article titled, "In Vivo and In-stantaneous Production of Chimeric Antigen Receptor T Cells: Overcoming Treatment Delays" talks about the in vivo and instantaneous production of chimeric antigen receptor T cells as a way to overcome potentially rate-limiting manufacturing times needed for current ex vivo technologies. You can find the Diffusion article online at www.hematology.org/Thehematologist/Diffusion/8464.aspx.

Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/